Professional Documents
Culture Documents
Wkly Review Sheet (1) - Ivy
Wkly Review Sheet (1) - Ivy
Ach Value
0
0
0
0
0
0
0
0
0
0
0
0
Calcinol 1000 Cerelyte Clotfre Domne Fericap
peso peso peso peso peso
units units units units units
value value value value value
- 10 1,350 - - -
10 2,000 - - - 6 3,600
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
10 2000 10 1350 0 0 0 0 6 3600
Isoflav CR Isoflav Gel Subsyde Takol CR Zytee Gel
peso peso peso peso peso
units units units units units
value value value value value
- - - - -
- - - - -
- - - - 10 2,500
- - - - 10 2,500
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
0 0 0 0 0 0 0 0 20 5000
163,820
TOTAL
1,350
5,600
2,500
2,500
25,500
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
37450
PRINTED NAME of MR:IVY MANLANGIT AREA OF COVERAGE: CEBU NORTH
Products
Products
March 17
Prescribing / Nearby / Target
Dispensing MD Pharmacy name
Secondary Focus product Week 1 Week 2 Week 3 Week 4
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
1 0
1 0
1 0
1 0
0 0
0 0
0 0
0 0
0 0
1 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
1 0
0 0
0 0
0 0
0 0
1 0
0 0
0 0
1 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
1 0
0 0
0 0
1 0
0 0
0 0
0 0
0 0
1 0
0 0
0 0
1 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Activity Sales (Disp / May 17 Activity
Planned / Prescriptions) Planned /
Expense
Conducted after Coverage Conducted
/ Proposed sponsorship Week 1 Week 2 Week 3 Week 4 / Proposed
Count
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Sales (Disp / June 17 Activity
Prescriptions) Planned /
Expense Expense
after Coverage Conducted
sponsorship Week 1 Week 2 Week 3 Week 4 / Proposed
Count
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Sales (Disp / July 17 Activity Sales (Disp /
Prescriptions) Planned / Prescriptions)
Expense
after Coverage Conducted after
sponsorship Week 1 Week 2 Week 3 Week 4 / Proposed sponsorship
Count
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Aug 17 Activity Sales (Disp / Oct 16
Planned / Prescriptions)
Expense
Week 1 Week 2 Week 3 Week 4 Coverage Conducted after
Week 1 Week 2
Count / Proposed sponsorship
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Oct 16 Activity Sales (Disp / Nov 16
Planned / Prescriptions)
Expense
Week 3 Week 4 Coverage Conducted after
Week 1 Week 2 Week 3
Count / Proposed sponsorship
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Nov 16 Activity Sales (Disp / Dec 16
Planned / Prescriptions)
Expense
Week 4 Coverage Conducted after
Week 1 Week 2 Week 3 Week 4
Count / Proposed sponsorship
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 0 0 0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0 0 0 0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 0 0 0 0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Sales (Disp /
Prescriptions)
after
sponsorship
Wk No : Date : MARCH 1
Total No of Coverage
Targeted for Primary Number Patients
Mercury / Drug Store 2X / Days
S.No Dr Name Focus of
4X for Focus (M/T/W/
(Name) / Dispensing Product Patients Product Th/F)
/ Day
Wk No : Date :
Total No of Coverage
Targeted for Primary Number Patients
Mercury / Drug Store 2X / Days
S.No Dr Name Focus of
4X for Focus (M/T/W/
(Name) / Dispensing Product Patients Product Th/F)
/ Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date : MARCH 2
Wk No : Date :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
MARCH 2 Wk No :
Total No of Coverage
Number Patients Preferred Trial
Days
of Coverage Pack / S.No Dr Name
for Focus (M/T/W/
Patients Product Time BAM
Th/F)
/ Day
TH BEFORE 10 1 FERNANDEZ,THELMA
TH BEFORE 10 2 CANETE,MELEN
TH BEFORE 10 3 ENTISE,LENA
TH BEFORE 10 4 PAILDE,MAR HAYEN
TH BEFORE 10 5 PHYLLIS,BOBON
TH BEFORE 10 6 ERAZO,ANDREW
TH BEFORE 10 7 PEREZ,REGINA
TH BEFORE 10 8 UY,ESTRELLA
TH BEFORE 10 9 TIRADO,ROSE MARIE
TH BEFORE 10 10 COBARDE,FEDINDO
TH BEFORE 10 11 VELASQUEZ,GALELIO
TH BEFORE 10 12 CATULONG,DEBRA
TH BEFORE 10 13 OBENZA,DOMINGA
TH BEFORE 10 14 TIRADO
TH BEFORE 10 15
TH BEFORE 10 16
TH BEFORE 10 17
TH BEFORE 10 18
Wk No :
Total No of Coverage
Number Patients Preferred Trial
Days
of Coverage Pack / S.No Dr Name
for Focus (M/T/W/
Patients Product Time BAM
Th/F)
/ Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : MARCH 3
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
RX 2X FERICAP F 10:30
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
RX 2X FERICAP F 10:30
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
RX 2X TAKOL F 10:30
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
RX 2X CERELYTE F 10:30
Date :
Total No of Coverage
Targeted for Primary Number Patients
Mercury / Drug Store 2X / Days
S.No Dr Name Focus of
4X for Focus (M/T/W/
(Name) / Dispensing Product Patients Product Th/F)
/ Day
1 FACTURAN,JUDY RX 2X FERICAP M
2 PURSUELO,HARHETT RX 2X ALFA M
3 VESTAL,MARIVIC RX 2X SUBSYDE M
4 TRANI,MA. ROSANA RX 2X SUBSYDE M
5 RANILE,HAMABAD RX 2X SUBSYDE M
6 ENRICUS,CHRISTIAN RX 2X TAKOL M
7 HOLAYSAN,GLENDA RX 2X CERELYTE M
8 ROSAL,CHRISTINE RX 2X FERICAP M
9 HAAS,ELLEN RX 2X FERICAP M
10 FACTURAN,RUBY RX 2X FERICAP M
11 MANGUBAT,MARILOU RX 2X FERICAP M
12 PANOPIA,HELEN RX 2X FERICAP M
13 HAAS,STEPHANIE RX 2X FERICAP M
14
15
16
17
18
Wk No : Date :
Total No of Coverage
Targeted for Primary Number Patients
Mercury / Drug Store 2X / Days
S.No Dr Name Focus of
4X for Focus (M/T/W/
(Name) / Dispensing Product Patients Product Th/F)
/ Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date : MARCH 7
Wk No : Date :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
MARCH 7 Wk No :
T 10:30 1
T 10:30 2
T 10:30 3
T 10:30 4
T 10:30 5
T 10:30 6
T 10:30 7
T 10:30 8
T 10:30 9
T 10:30 10
T 10:30 11
T 10:30 12
T 10:30 13
T 10:30 14
T 10:30 15
T 10:30 16
T 10:30 17
18
Wk No :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date : MARCH 8
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients
Drug Days
Dr Name 2X / 4X Focus of Coverage
Store for Focus (M/T/W/
Product Patients / Product Time
(Name) / Th/F)
Day
Dispensin
g
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients
Drug Days
Dr Name 2X / 4X Focus of Coverage
Store for Focus (M/T/W/
Product Patients / Product Time
(Name) / Th/F)
Day
Dispensin
g
Wk No : Date :MARCH 9
Targeted
for Total
Mercury /
Trial Primary Number
Drug
Pack / S.No Dr Name 2X / 4X Focus of
Store
BAM Product Patients /
(Name) / Day
Dispensin
g
Wk No : Date :
Targeted
for Total
Mercury /
Trial Primary Number
Drug
Pack / S.No Dr Name 2X / 4X Focus of
Store
BAM Product Patients /
(Name) / Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date : MARCH 10
Targeted
for
No of Coverage Preferred Mercury /
Trial
Patients Days Drug
for Focus (M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X
Store
Time BAM
Product Th/F) (Name) /
Dispensin
g
TH 1 FERNANDEZ,THELMA RX 2X
TH 2 CANETE,MELEN RX 2X
TH 3 ENTISE,LENA RX 2X
TH 4 PAILDE,MAR HAYEN RX 2X
TH 5 PHYLLIS,BOBON RX 2X
TH 6 ERAZO,ANDREW RX 2X
TH 7 PEREZ,REGINA RX 2X
TH 8 UY,ESTRELLA RX 2X
TH 9 TIRADO,ROSE MARIE RX 2X
TH 10 COBARDE,FEDINDO RX 2X
TH 11 VELASQUEZ,GALELIO RX 2X
TH 12 CATULONG,DEBRA RX 2X
TH 13 OBENZA,DOMINGA RX 2X
TH 14 TIRADO RX 2X
TH 15
TH 16
TH 17
TH 18
Wk No : Date :
Targeted
for
No of Coverage Preferred Mercury /
Trial
Patients Days Drug
for Focus (M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X
Store
Time BAM
Product Th/F) (Name) /
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : MARCH 10 Wk No :
Date : Wk No :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date :MARCH 13 Wk No :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
2X / 4X Focus of Coverage Pack / S.No
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
RX 2X TAKOL M 10:30 1
RX 2X ISO CR M 10:30 2
RX 2X CERELYTE M 10:30 3
RX 2X FERICAP M 10:30 4
RX 2X FERICAP M 10:30 5
RX 2X CERELYTE M 10:30 6
RX 2X CERELYTE M 10:30 7
RX 2X CERELYTE M 10:30 8
RX 2X ALFA M 10:30 9
RX 2X ALFA M 10:30 10
RX 2X ALFA M 10:30 11
RX 2X ALFA M 10:30 12
RX 2X ALFA M 10:30 13
RX 2X CERELYTE M 10:30 14
RX 2X ALFA M 10:30 15
RX 2X CERELYTE M 10:30 16
DISPENSING 2X CERELYTE M 10:30 17
18
Date : Wk No :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
2X / 4X Focus of Coverage Pack / S.No
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :MARCH 14
Total
Targeted for No of Coverage Preferred
Primary Number Patients
Mercury / Drug Days
Dr Name 2X / 4X Focus of Coverage
Store (Name) / for Focus (M/T/W/
Product Patients / Product Time
Dispensing Th/F)
Day
LAPU-LAPU AREA
I WILL ADD SOON FOR DISPENSING DOCTORS ONCE I WILL BE ABLE TO FIND SOME DOCTORS
WHO ARE DISPENSING..
Wk No : Date :
Total
Targeted for No of Coverage Preferred
Primary Number Patients
Mercury / Drug Days
Dr Name 2X / 4X Focus of Coverage
Store (Name) / for Focus (M/T/W/
Product Patients / Product Time
Dispensing Th/F)
Day
Wk No : Date : MARCH 15
Targeted
for Total
Mercury / No of
Trial Primary Number Patients
Drug
Pack / S.No Dr Name 2X / 4X Focus of
Store Product Patients / for Focus
BAM (Name) / Product
Day
Dispensin
g
Wk No : Date :
Targeted
for Total
Mercury / No of
Trial Primary Number Patients
Drug
Pack / S.No Dr Name 2X / 4X Focus of
Store Product Patients / for Focus
BAM (Name) / Product
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :MARCH 16
Targeted
for
Coverage Preferred Mercury /
Trial
Days Drug
(M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X
Store
Time BAM
Th/F) (Name) /
Dispensin
g
W BEFORE 11 1 PIRAMIDE,ARCELIN RX
W BEFORE 11 2 DAUTIL,MYRABELL RX
W BEFORE 11 3 LEE,EDUARDO RX
W BEFORE 11 4 SUAREZ,JUDY RX
W BEFORE 11 5 GERRA,LYNNETH RX
W BEFORE 11 6 VELOSO,MARY GERLIE RX
W BEFORE 11 7 HERNANDEZ,SHALIMAR RX
W BEFORE 11 8 LEYCO,THERESA RX
W BEFORE 11 9 MUNTUERTO,ADELE RX
W BEFORE 11 10 TORRIZO,MARBEE RX
W BEFORE 11 11 FAELNAR,LOIDA RX
W BEFORE 11 12 LAFUENTE,LEAH RX
W BEFORE 11 13 GO,LORIFEL RX
W BEFORE 11 14 IBAY,CHERYL RX
W BEFORE 11 15 AMORIN,HELEN RX
W BEFORE 11 16 CASTRO,LEIDENIA RX
17 CHIN,JAMES RX
18 BLATERIA,ADONIS RX
Wk No : Date :
Targeted
for
Coverage Preferred Mercury /
Trial
Days Drug
(M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X
Store
Time BAM
Th/F) (Name) /
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date :MARCH 16 Wk No :
Date : Wk No :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : MARCH 17 Wk No :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
2X / 4X Focus of Coverage Pack / S.No
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
RX 2X CERELYTE F 10:30 1
RX 2X CERELYTE F 10:30 2
RX 2X CERELYTE F 10:30 3
RX 2X FERICAP F 10:30 4
RX 2X CERELYTE F 10:30 5
RX 2X CERELYTE F 10:30 6
RX 2X FERICAP F 10:30 7
RX 2X CERELYTE F 10:30 8
RX 2X CERELYTE F 10:30 9
RX 2X TAKOL F 10:30 10
RX 2X CERELYTE F 10:30 11
RX 2X CERELYTE F 10:30 12
RX 2X CERELYTE F 10:30 13
RX 2X CERELYTE F 10:30 14
15
16
17
18
Date : Wk No :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
2X / 4X Focus of Coverage Pack / S.No
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
Dr Name 2X / 4X Focus of Coverage Pack /
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
Dr Name 2X / 4X Focus of Coverage Pack /
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
S.No Dr Name 2X / 4X Focus of Coverage Pack /
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
S.No Dr Name 2X / 4X Focus of Coverage Pack /
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients
Drug Days
S.No Dr Name 2X / 4X Focus of Coverage
Store for Focus (M/T/W/
Product Patients / Product Time
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients
Drug Days
S.No Dr Name 2X / 4X Focus of Coverage
Store for Focus (M/T/W/
Product Patients / Product Time
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage
Trial Primary Number Patients
Drug Days
Pack / S.No Dr Name 2X / 4X Focus of
Store for Focus (M/T/W/
BAM Product Patients / Product
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of Coverage
Trial Primary Number Patients
Drug Days
Pack / S.No Dr Name 2X / 4X Focus of
Store for Focus (M/T/W/
BAM Product Patients / Product
(Name) / Th/F)
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of
Preferred Trial Primary Number Patients
Drug
Coverage Pack / S.No Dr Name 2X / 4X Focus of
Store Product Patients / for Focus
Time BAM (Name) / Product
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Mercury / No of
Preferred Trial Primary Number Patients
Drug
Coverage Pack / S.No Dr Name 2X / 4X Focus of
Store Product Patients / for Focus
Time BAM (Name) / Product
Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Coverage Preferred Mercury /
Trial Primary Number
Days Drug
(M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X Focus of
Store
Time BAM Product Patients /
Th/F) (Name) / Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for Total
Coverage Preferred Mercury /
Trial Primary Number
Days Drug
(M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X Focus of
Store
Time BAM Product Patients /
Th/F) (Name) / Day
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for
No of Coverage Preferred Mercury /
Trial Primary
Patients Days Drug
for Focus (M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X Focus
Store
Time BAM Product
Product Th/F) (Name) /
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for
No of Coverage Preferred Mercury /
Trial Primary
Patients Days Drug
for Focus (M/T/W/ Coverage Pack / S.No Dr Name 2X / 4X Focus
Store
Time BAM Product
Product Th/F) (Name) /
Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for
Total No of Coverage Preferred Mercury /
Number Patients Trial
Days Drug
of Coverage Pack / S.No Dr Name 2X / 4X
for Focus (M/T/W/ Store
Patients / Product Time BAM
Th/F) (Name) /
Day Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Wk No : Date :
Targeted
for
Total No of Coverage Preferred Mercury /
Number Patients Trial
Days Drug
of Coverage Pack / S.No Dr Name 2X / 4X
for Focus (M/T/W/ Store
Patients / Product Time BAM
Th/F) (Name) /
Day Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : Wk No :
Targeted
for
Total No of Coverage Preferred Mercury /
Primary Number Patients Trial
Days Drug
Focus of Coverage Pack / S.No Dr Name
for Focus (M/T/W/ Store
Product Patients / Product Time BAM
Th/F) (Name) /
Day Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : Wk No :
Targeted
for
Total No of Coverage Preferred Mercury /
Primary Number Patients Trial
Days Drug
Focus of Coverage Pack / S.No Dr Name
for Focus (M/T/W/ Store
Product Patients / Product Time BAM
Th/F) (Name) /
Day Dispensin
g
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : Wk No :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date : Wk No :
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
2X / 4X Focus of Coverage Pack /
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
Date :
Targeted
for Total
Mercury / No of Coverage Preferred
Primary Number Patients Trial
Drug Days
2X / 4X Focus of Coverage Pack /
Store for Focus (M/T/W/
Product Patients / Product Time BAM
(Name) / Th/F)
Day
Dispensin
g
Dr Name Speciality Disp / Prescribing Meeting timings Primary focus product
LEE JAMES MARATAS PEDIA DISP ZYTEE
MINA TAGRA OB DISP ISOCR/GEL
Existing sales in Value Fronting Drug store Products available
2500
49700
Dr Name Speciality Disp / Prescribing Meeting timings Primary focus product
ROMMEL CAPA PEDIA DISP CERELYTE
MARGIEYL CAPA OB DISP FERICAP/CALCINOL
RENAN DUNGOG IM RX ALFA
LOURDES ATOC OB RX FERICAP/CALCINOL
EDGAR ALVAR PEDIA RX CERELYTE/ZYTEE
Fronting Drug storeProducts available
MERCURY
ROSE PHARMACY
ROSE PHARMACY
Dr Name Speciality Disp / Prescribing Meeting timings Primary focus product
Expected Tie-up Proposed Discount /
Fronting Drug store Products available Sales Value Sponsorship
Type of Month of Primary Proposed Sales of
Dispensing /
S.No Dr Name Activity Activity Focus Expense last 3
Prescriber
Planned Planned product (Peso) months
Expected Expected Actual Actual
Expected Actual
sales sales 2 sales sales 2
sales next sales next
during months during months
month of month of
month of after month of after
activity activity
activity activity activity activity
(Peso) (Peso)
(Peso) (Peso) (Peso) (Peso)
Branch Name of Store
Mercury Branch Name Product Name of Selected Dr Speciality
Code Incharge
Calcinol
DUNGOG,RENAN IM
Alfacalcinol
PINUNGGAN,JOSELITO OB
MACTAN BRANCH Isoflav CR
ATOC,LOURDES OB
PINUNGGAN,JOSELITO OB
Isoflav Gel
ATOC,LOURDES OB
PINUNGGAN,JOSELITO OB
Fericap CR
ATOC,LOURDES OB
Calcinol
Alfacalcinol
Isoflav Gel
Fericap CR
Calcinol
Alfacalcinol
Isoflav Gel
Fericap CR
Calcinol
Alfacalcinol
Isoflav CR
Isoflav Gel
Fericap CR
Calcinol
Alfacalcinol
Isoflav CR
Isoflav Gel
Fericap CR
Calcinol
Calcinol
Alfacalcinol
Isoflav CR
Isoflav Gel
Fericap CR
Calcinol
Alfacalcinol
Isoflav CR
Isoflav Gel
Fericap CR
Remarks Date of coverage
NO AVAILABALE 3/7/2017
PRODUCT
NO AVAILABLE 3/10/2017
PRODUCT
NO AVAILABLE
PRODUCT
3/9/2017
Targeted Dispensing /
S.No Dr Name Dr Speciality Product Prescribing
1 CAPA,ROMMEL PEDIA CERELYTE DISPENSING
2 NOVAL,RJ PEDIA CERELYTE DISPENSING
3 PITOGO,HARRY PEDIA CERELYTE DISPENSING
4
5
6
7
8
9
10
Targeted Dispensing /
S.No Dr Name Dr Speciality Product Prescribing
1 MARGIEYL CAPA OB FERICAP DISPENSING
2
3
4
5
6
7
8
9
10
Targeted Dispensing /
S.No Dr Name Dr Speciality Product Prescribing
1 MINA TAGRA OB ALFA DISPENSING
2 FE MERIN OB ALFA DISPENSING
3
4
5
6
7
8
9
10
Targeted Dispensing /
S.No Dr Name Dr Speciality Product Prescribing
1
2
3
4
5
6
7
8
9
10
Expected Order in Date of Visit planned in
Units March 17
27-Mar 10
27-Mar 10
27-Mar 10
Alfacalcinol 52 26520 0 0
Clotfre 13 2600 0 0
Domne 85 11475 0 0
Fericap CR 44 26400 0 0
Isoflav CR 15 20250 0 0
Subsyde CR 12 3000 0 0
Takol CR 14 43400 0 0
232420 0 0
Reasons for Deviation from planned sales figure
Itenerary
Name IVY C. MANALANGIT
Month : MARCH 2017
Date Place of Work No. of Drs Planned Visit Objectives
1 MENDERO HOSPITAL 14 COVER/GET SOME ORDER FOR DISPENSING DOC
2 UCMED 18 COVER
3 MANDAUE TERRITORIALS 12 COVER
4
5
6 PERPETUAL 15 COVER
7 MACTAN DOC HOSPITAL 16 COVER
8 MENDERO HOSPITAL 14 COVER/GET SOME ORDER FOR DISPENSING DOC
9 UCMED 18 COVER
10 MANDAUE TERRITORIALS 12 COVER
11
12
13 MACTAN DOC HOSPITAL 16 COVER
14 LAPU-LAPU TERRITORIAL DISPENSING DOCTORS
15 MENDERO HOSPITAL 14 COVER
16 PERPETUAL 16 COVER
17 MANDAUE TERRITORIALS 16 DISPENSING DOCTORS
18
19
20 LAPU-LAPU TERRITORIAL 16 COVER
21 MACTAN DOC HOSPITAL 16 COVER
22 MENDERO HOSPITAL 16 COVER
23 TACLOBAN 16 COLLECTION/COVER
24 TACLOBAN COLLECTION/COVER
25
26
27 MACTAN DOC HOSPITAL 16 COVER
28 LAPU-LAPU TERRITORIAL 16 COVER
29 MENDERO HOSPITAL 16 COVER
30 UCMED 16 COVER
31 MANDAUE TERRITORIALS 16 COVER
FOR DISPENSING DOCTORS
MACTAN 7
LAPU 1
UC 3 3 3 15
PERPETUAL 4
MENDERO 1
CCDI 2
LH PRIME
CORTES
Family
General
Surgeon Pediatrition ENDO OB Nephro Medicine / Others
Practice
IM
1 7 1 4 14
1 1 1
5 17 14 7
1 1 7
8 3
1 1
1 3 3 8
Total
Number
34
67
13
12
15
124
4
1 10 2 2
2 3 3
April May June
Sr. No. Product Packing SRP Target Achivement Target Achivement Target
0 0 0 0 0
November December January February March
Target Achivement Target Achivement Target Achivement Target Achivement Target
52
72
135
85
44
15
45
12
14
15
0 0 0 0
March
Achivement
0
RAPTAKOS BRETT & COMPANY, PHILIPPINES
Last Updated on
ACTUAL
MD'S COVERED NO. OF CLASS SPCLTY AC
VISITS
Alfa CAL
STARTING BALANCE
SAMPLE RECEIVED
GIVEN TODAY
ENDING BALANCE
DRUGSTORE COVERED
NUMBER OF CALLS MD'S D/S
TODAY
TOTAL YESTERDAY
TOTAL TO DATE/MONTH
tt & Co., Ltd.
., Salcedo Village, Makati City
840-0236
GE REPORT
ATE COVERED:
SAMPLES GIVEN
REMARKS
PMR'S SIGNATURE
KM.
Date Itinerary Area Covered No of MD Met GAS
Reading
T O TAL
OBJECTIVE
EMPLOYEE'S SIGNATURE :
DATE SENT :
Checked by:
REGION MANAGER
Approved by:
GEN. MANAGER
Released by:
FINANCE
Sponsorship form
Type of Activity :
Region : DM Name :
Date of Application :
Month Apr May Jun Jul Aug
MR Name :
Sec. Sales SRP (Peso )
Value of Sponsorship SRP (Peso
)
Amt to be
Reasons for Sponsorship Date & Nature of Sponsorship
Sponsored $
Expected Business
Per Month for 3 Name of MD
months
Unit Value Qualification
Speciality
Complete Mailing Address of
MD
Bank transfer / Cheque to be Name
issued by Place
Cheque / Bank transfer / DD / Name
Fund transfer in favour of Place
Last sponsorship extended, amount Which are the other companies sponsoring
Date & Nature of Sponsorship
involved & date (mention amount/event)
Name / Signature of MR
Name / Signature of DM
Signature of CM
ett & Co LTD
Total
-
-
ompanies sponsoring
mount/event)
Value (Php)
YTD Spent
Raptakos, Brett & Co., Ltd.
Unit 511 Cityland 10 Tower 1, H.V. Dela Costa St., Salcedo Village, Makati City Telefax: (632) 840-0236
CUSTOMER'S NAME :
ADDRESS :
TELEPHONE NO. :
CONTACT PERSON :
DELIVERY INSTRUCTION :
PRODUCT CODE
R B 0 0 0 0 4
R B 0 0 0 0 5
R B 0 0 0 0 7
R B 0 0 0 0 9
R B 0 0 0 1 0
R B 0 0 0 1 1
R B 0 0 0 1 5
R B 0 0 0 1 6
PMR SIGNATURE
SALES ORDER
ett & Co., Ltd. No.
elefax: (632) 840-0236
DATE :
TERMS :
CUST. CODE :
FREE UNIT
PRODUCTS QUANTITY GOODS PRICE AMOUNT
ISOFLAV-CR CAPSULES 100'S 3,100.00 0
ISOFLAV GEL 20G 250.00 0
SUBSYDE CR CAPSULES 100's 1,350.00 0
ALFA CALCINOL TABLETS 30'S 510.00 0
CERELYTE 5 SACHETS 135.00 0
ZYTEE GEL 10ML 250.00 0
CALCINOL-1000 10 SACHETS 200.00 0
FERICAP CR 100'S 600.00 0
CLOTFREE 75MG TABS 400.00 0
DOMNE 180.00 0
TOTAL 0
CUSTOMER'S SIGNATURE
ES ORDER
REMARKS/
APPROVAL